OneChain is a spin-off company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop immunotherapies against hematological neoplasms using CAR-T candidates against different antigens.
Biotechnology, Life Science
Between €2.5 million-5 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as OneChain? We’re happy to assist you with our Startup Sourcing service.